Cargando…

Traditional Chinese medicine in thyroid-associated orbitopathy

PURPOSE: Orbital fibroblasts (OF) are considered the central target cells in the pathogenesis of thyroid-associated orbitopathy (TAO), which comprises orbital inflammation, orbital tissue edema, adipogenesis, fibrosis, oxidative stress and autophagy. Certain active ingredients of traditional Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hai, Y. P., Lee, A. C. H., Chen, K., Kahaly, G. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Short Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185651/ https://www.ncbi.nlm.nih.gov/pubmed/36781592 http://dx.doi.org/10.1007/s40618-023-02024-4

Ejemplares similares

Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2020)

Thyroid associated orbitopathy
por: Maheshwari, Rajat, et al.
Publicado: (2012)

Thyroid Stimulating but Not Blocking Autoantibodies Are Highly Prevalent in Severe and Active Thyroid-Associated Orbitopathy: A Prospective Study
por: Kampmann, E., et al.
Publicado: (2015)

Graves' Orbitopathy
por: Hiromatsu, Yuji, et al.
Publicado: (2015)

Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy
por: Sarić-Matutinović, Marija, et al.
Publicado: (2022)

Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application
por: Längericht, Jan, et al.
Publicado: (2020)

Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021)

Thiazolidinedione induced thyroid associated orbitopathy
por: Lee, Seongmu, et al.
Publicado: (2007)

SAT-429 Systemic Safety Analysis of Mycophenolate in Graves’ Orbitopathy
por: Lee, Alan C H, et al.
Publicado: (2020)

Treatment modalities of thyroid related orbitopathy
por: Ahn, Eric S, et al.
Publicado: (2014)

Thyroid Associated Orbitopathy Following Periocular Surgery
por: Kim, Sang June, et al.
Publicado: (2006)

Perspectives in the management of thyroid orbitopathy
por: Daroszewski, Jacek
Publicado: (2013)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy
por: Choi, Catherine J., et al.
Publicado: (2018)

Clinical Significance of Corneal Striae in Thyroid Associated Orbitopathy
por: Liao, Xulin, et al.
Publicado: (2023)

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
por: Perros, P., et al.
Publicado: (2017)

Doppler imaging of orbital vessels in the assessment of the activity and severity of thyroid-associated orbitopathy
por: Walasik-Szemplińska, Dorota, et al.
Publicado: (2015)

Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review
por: Hodgson, Nickisa M., et al.
Publicado: (2019)

Risk Factors Associated with the Severity of Thyroid-Associated Orbitopathy in Korean Patients
por: Lee, Ji Hwan, et al.
Publicado: (2010)

Assessment of Choroidal Vascularity in Inactive Thyroid Associated Orbitopathy
por: Pehlivanoglu, Seren, et al.
Publicado: (2023)

Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra
por: Ackuaku-Dogbe, Edith Mawunyo, et al.
Publicado: (2017)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

Electrophysiological Studies in Thyroid Associated Orbitopathy: A Systematic Review
por: Iao, Tiara W. U., et al.
Publicado: (2017)

Fat-removal orbital decompression for thyroid associated orbitopathy: The right procedure for the right patient
por: Al-Sharif, Eman, et al.
Publicado: (2017)

Versorgungsrelevante Daten einer interdisziplinären Sprechstunde für endokrine Orbitopathie
por: Ponto, Katharina A., et al.
Publicado: (2020)

New evidence concerning the pathomechanism and treatment of thyroid associated orbitopathy
por: Daroszewski, Jacek
Publicado: (2015)

SUN-569 Thyroid Associated Orbitopathy (TAO): An Unusual Presentation
por: Costa, Cláudia, et al.
Publicado: (2019)

Change in eyelid parameters after orbital decompression in thyroid-associated orbitopathy
por: Park, Hong Hyun, et al.
Publicado: (2018)

Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future
por: Turck, Natacha, et al.
Publicado: (2018)

Thyroid-associated orbitopathy in patients with thyroid carcinoma: A case report of 5 cases
por: Yu, Peng, et al.
Publicado: (2017)

A case report of thyroid-associated Orbitopathy with elevated TPO antibodies
por: El Othman, Radwan, et al.
Publicado: (2020)

Dural Carotid-cavernous Fistula Mimicking Thyroid Orbitopathy
por: Pelit, Aysel, et al.
Publicado: (2019)

Isolated Lacrimal Gland Enlargement in Thyroid-Related Orbitopathy
por: Yahalomi, Tal, et al.
Publicado: (2021)

Subconjunctival orbital fat prolapse and thyroid associated orbitopathy: a clinical association
por: Chatzistefanou, Klio I, et al.
Publicado: (2017)

Evaluation of the association between subconjunctival orbital fat prolapse and thyroid-associated orbitopathy
por: Han, Sang Beom
Publicado: (2017)

Hertel exophthalmometer versus computed tomography scan in proptosis estimation in thyroid-associated orbitopathy
por: Park, Na Ri, et al.
Publicado: (2019)

Rapamycin improves Graves’ orbitopathy by suppressing CD4(+) cytotoxic T lymphocytes
por: Zhang, Meng, et al.
Publicado: (2023)

Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine
por: Seto, S. W., et al.
Publicado: (2015)

Current Knowledge on Graves’ Orbitopathy
por: Gontarz-Nowak, Katarzyna, et al.
Publicado: (2020)

YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery
por: Li, Baiqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1fgkhlpo85sq6ffrdqinfki9tt